Sfoglia per Autore
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.
2000-01-01 Bronte, Vincenzo; E., Apolloni; A., Cabrelle; R., Ronca; P., Serafini; P., Zamboni; N. P., Restifo; P., Zanovello
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.
2000-01-01 Bronte, Vincenzo; E., Apolloni; R., Ronca; P., Zamboni; W. W., Overwijk; D. R., Surman; N. P., Restifo; P., Zanovello
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.
2001-01-01 S. K., Mendiratta; G., Thai; N. K., Eslahi; N. M., Thull; M., Matar; Bronte, Vincenzo; F., Pericle
Genetic vaccination for the active immunotherapy of cancer.
2001-01-01 Bronte, Vincenzo
Tumor-induced immune dysfunctions caused by myeloid suppressor cells.
2001-01-01 Bronte, Vincenzo; P., Serafini; E., Apolloni; P., Zanovello
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.
2002-01-01 A., Mazzoni; Bronte, Vincenzo; A., Visintin; J. H., Spitzer; E., Apolloni; P., Serafini; P., Zanovello; D. M., Segal
L-arginine metabolism in myeloid cells controls T-lymphocyte functions.
2003-01-01 Bronte, Vincenzo; P., Serafini; A., Mazzoni; D. M., Segal; P., Zanovello
Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation.
2003-01-01 E., Cozzi; R., Cadrobbi; N., Baldan; A., Dedja; F., Calabrese; M., Castagnaro; F., Fante; M., Boldrin; I., Iacopetti; L., Ravarotto; P., Carraro; Bronte, Vincenzo; C. D., Santo; R., Busetto; M., Plebani; F. M., Cancellotti; P., Rigotti; G., Thiene; E., Ancona
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase.
2003-01-01 Bronte, Vincenzo; S., Cingarlini; E., Apolloni; P., Serafini; I., Marigo; C. D., Santo; B., Macino; O., Marin; P., Zanovello
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
2003-01-01 Bronte, Vincenzo; P., Serafini; C. D., Santo; I., Marigo; V., Tosello; A., Mazzoni; D. M., Segal; C., Staib; M., Lowel; G., Sutter; M. P., Colombo; P., Zanovello
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response.
2004-01-01 L., Sfondrini; D., Besusso; Bronte, Vincenzo; B., Macino; A., Rossini; M. P., Colombo; S., Ménard; A., Balsari
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes.
2004-01-01 R. D., Palma; I., Marigo; F. D., Galdo; C. D., Santo; P., Serafini; S., Cingarlini; T., Tüting; J., Lenz; G., Basso; G., Milan; P., Zanovello; Bronte, Vincenzo
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.
2004-01-01 P., Serafini; R., Carbley; K. A., Noonan; G., Tan; Bronte, Vincenzo; I., Borrello
Cancer vaccines: pessimism in check.
2004-01-01 S., Mocellin; S., Mandruzzato; Bronte, Vincenzo; F. M., Marincola
Part I: Vaccines for solid tumours.
2004-01-01 S., Mocellin; S., Mandruzzato; Bronte, Vincenzo; M., Lise; D., Nitti
Derangement of immune responses by myeloid suppressor cells.
2004-01-01 P., Serafini; C. D., Santo; I., Marigo; S., Cingarlini; L., Dolcetti; G., Gallina; P., Zanovello; Bronte, Vincenzo
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.
2005-01-01 Bronte, Vincenzo; T., Kasic; G., Gri; K., Gallana; G., Borsellino; I., Marigo; L., Battistini; M., Iafrate; T., Prayer Galetti; F., Pagano; A., Viola
Regulation of immune responses by L-arginine metabolism.
2005-01-01 Bronte, Vincenzo; P., Zanovello
Cancer immunotherapy based on killing of Salmonella-infected tumor cells.
2005-01-01 F., Avogadri; C., Martinoli; L., Petrovska; C., Chiodoni; P., Transidico; Bronte, Vincenzo; R., Longhi; M. P., Colombo; G., Dougan; M., Rescigno
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.
2005-01-01 C. D., Santo; P., Serafini; I., Marigo; L., Dolcetti; M., Bolla; P. D., Soldato; C., Melani; C., Guiducci; M. P., Colombo; M., Iezzi; P., Musiani; P., Zanovello; Bronte, Vincenzo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. | 1-gen-2000 | Bronte, Vincenzo; E., Apolloni; A., Cabrelle; R., Ronca; P., Serafini; P., Zamboni; N. P., Restifo; P., Zanovello | |
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo. | 1-gen-2000 | Bronte, Vincenzo; E., Apolloni; R., Ronca; P., Zamboni; W. W., Overwijk; D. R., Surman; N. P., Restifo; P., Zanovello | |
Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. | 1-gen-2001 | S. K., Mendiratta; G., Thai; N. K., Eslahi; N. M., Thull; M., Matar; Bronte, Vincenzo; F., Pericle | |
Genetic vaccination for the active immunotherapy of cancer. | 1-gen-2001 | Bronte, Vincenzo | |
Tumor-induced immune dysfunctions caused by myeloid suppressor cells. | 1-gen-2001 | Bronte, Vincenzo; P., Serafini; E., Apolloni; P., Zanovello | |
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. | 1-gen-2002 | A., Mazzoni; Bronte, Vincenzo; A., Visintin; J. H., Spitzer; E., Apolloni; P., Serafini; P., Zanovello; D. M., Segal | |
L-arginine metabolism in myeloid cells controls T-lymphocyte functions. | 1-gen-2003 | Bronte, Vincenzo; P., Serafini; A., Mazzoni; D. M., Segal; P., Zanovello | |
Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. | 1-gen-2003 | E., Cozzi; R., Cadrobbi; N., Baldan; A., Dedja; F., Calabrese; M., Castagnaro; F., Fante; M., Boldrin; I., Iacopetti; L., Ravarotto; P., Carraro; Bronte, Vincenzo; C. D., Santo; R., Busetto; M., Plebani; F. M., Cancellotti; P., Rigotti; G., Thiene; E., Ancona | |
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. | 1-gen-2003 | Bronte, Vincenzo; S., Cingarlini; E., Apolloni; P., Serafini; I., Marigo; C. D., Santo; B., Macino; O., Marin; P., Zanovello | |
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. | 1-gen-2003 | Bronte, Vincenzo; P., Serafini; C. D., Santo; I., Marigo; V., Tosello; A., Mazzoni; D. M., Segal; C., Staib; M., Lowel; G., Sutter; M. P., Colombo; P., Zanovello | |
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response. | 1-gen-2004 | L., Sfondrini; D., Besusso; Bronte, Vincenzo; B., Macino; A., Rossini; M. P., Colombo; S., Ménard; A., Balsari | |
Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. | 1-gen-2004 | R. D., Palma; I., Marigo; F. D., Galdo; C. D., Santo; P., Serafini; S., Cingarlini; T., Tüting; J., Lenz; G., Basso; G., Milan; P., Zanovello; Bronte, Vincenzo | |
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. | 1-gen-2004 | P., Serafini; R., Carbley; K. A., Noonan; G., Tan; Bronte, Vincenzo; I., Borrello | |
Cancer vaccines: pessimism in check. | 1-gen-2004 | S., Mocellin; S., Mandruzzato; Bronte, Vincenzo; F. M., Marincola | |
Part I: Vaccines for solid tumours. | 1-gen-2004 | S., Mocellin; S., Mandruzzato; Bronte, Vincenzo; M., Lise; D., Nitti | |
Derangement of immune responses by myeloid suppressor cells. | 1-gen-2004 | P., Serafini; C. D., Santo; I., Marigo; S., Cingarlini; L., Dolcetti; G., Gallina; P., Zanovello; Bronte, Vincenzo | |
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. | 1-gen-2005 | Bronte, Vincenzo; T., Kasic; G., Gri; K., Gallana; G., Borsellino; I., Marigo; L., Battistini; M., Iafrate; T., Prayer Galetti; F., Pagano; A., Viola | |
Regulation of immune responses by L-arginine metabolism. | 1-gen-2005 | Bronte, Vincenzo; P., Zanovello | |
Cancer immunotherapy based on killing of Salmonella-infected tumor cells. | 1-gen-2005 | F., Avogadri; C., Martinoli; L., Petrovska; C., Chiodoni; P., Transidico; Bronte, Vincenzo; R., Longhi; M. P., Colombo; G., Dougan; M., Rescigno | |
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. | 1-gen-2005 | C. D., Santo; P., Serafini; I., Marigo; L., Dolcetti; M., Bolla; P. D., Soldato; C., Melani; C., Guiducci; M. P., Colombo; M., Iezzi; P., Musiani; P., Zanovello; Bronte, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile